Atrys Health SL (ATRY) - Total Liabilities

Latest as of June 2026: €168.11 Million EUR ≈ $196.53 Million USD

Based on the latest financial reports, Atrys Health SL (ATRY) has total liabilities worth €168.11 Million EUR (≈ $196.53 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check ATRY cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Atrys Health SL - Total Liabilities Trend (2012–2025)

This chart illustrates how Atrys Health SL's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see balance sheet size of Atrys Health SL.

Atrys Health SL Competitors by Total Liabilities

The table below lists competitors of Atrys Health SL ranked by their total liabilities.

Company	Country	Total Liabilities
Tah Hsin Industrial Corp TW:1315	Taiwan	NT$994.94 Million
Arwana Citramulia Tbk JK:ARNA	Indonesia	Rp961.96 Billion
Thirumalai Chemicals Limited NSE:TIRUMALCHM	India	Rs28.12 Billion
Rxsight Inc NASDAQ:RXST	USA	$89.36 Million
Naturgy BAN SA BA:GBAN	Argentina	AR$381.10 Billion
TerrAscend Corp F:TED	Germany	€458.36 Million
AG Mortgage Investment Trust Inc NYSE:MITT	USA	$7.74 Billion
High Tide Inc NASDAQ:HITI	USA	$244.82 Million

Liability Composition Analysis (2012–2025)

This chart breaks down Atrys Health SL's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See ATRY net asset quality score to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.47	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.14	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.53	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Atrys Health SL's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Atrys Health SL (2012–2025)

The table below shows the annual total liabilities of Atrys Health SL from 2012 to 2025.

Year	Total Liabilities	Change
2025-12-31	€342.08 Million ≈ $399.93 Million	+3.36%
2024-12-31	€330.95 Million ≈ $386.92 Million	-2.41%
2023-12-31	€339.12 Million ≈ $396.47 Million	-7.77%
2022-12-31	€367.71 Million ≈ $429.89 Million	+26.08%
2021-12-31	€291.65 Million ≈ $340.97 Million	+190.35%
2020-12-31	€100.45 Million ≈ $117.43 Million	+108.88%
2019-12-31	€48.09 Million ≈ $56.22 Million	+76.47%
2018-12-31	€27.25 Million ≈ $31.86 Million	+61.25%
2017-12-31	€16.90 Million ≈ $19.76 Million	+3.64%
2016-12-31	€16.31 Million ≈ $19.06 Million	+13.27%
2015-12-31	€14.40 Million ≈ $16.83 Million	+14.17%
2014-12-31	€12.61 Million ≈ $14.74 Million	+2.90%
2013-12-31	€12.25 Million ≈ $14.33 Million	+0.14%
2012-12-31	€12.24 Million ≈ $14.31 Million	--

About Atrys Health SL

MC:ATRY Spain Biotechnology

Market Cap

$252.92 Million

€216.34 Million EUR

Market Cap Rank

#16576 Global

#109 in Spain

Share Price

€2.85

Change (1 day)

+0.18%

52-Week Range

€2.34 - €3.51

All Time High

€11.20